Conference - Events
Featured Events
Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond. From pioneering the next generation of CAR-M therapies to unveiling novel targets, this field is on a mission to learn from the past and spearhead pipelines into clinical development.
With that, the 6th Macrophage-Directed Therapies Summit will return to Boston this year, uniting 60+ biopharma and academia leaders across R and D, Discovery, Biology, Translational, and Clinical Development fields. As a uniquely positioned platform, this event is perfect for those committed to reigniting excitement in macrophage pipeline advancement.
This is your chance to gain exclusive insig…
Attention all Macrophage Experts! ๐ข
If you're looking to learn from the past and ๐ฝ๐ฟ๐ผ๐ฝ๐ฒ๐น ๐๐ผ๐๐ฟ ๐บ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐๐ผ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ, look no further than the ๐ฒ๐๐ต ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ-๐๐ถ๐ฟ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐ฆ๐๐บ๐บ๐ถ๐!
๐๐๐น๐น ๐๐ด๐ฒ๐ป๐ฑ๐ฎ ๐๐ฒ๐ฟ๐ฒ โก๏ธ https://ter.li/mio6hu
๐จ๐ป๐ถ๐๐ถ๐ป๐ด ๐ฒ๐ฌ+ ๐ฏ๐ถ๐ผ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ ๐ฎ๐ป๐ฑ ๐ฎ๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฎ ๐น๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐ across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.๐ก
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐๐ต๐ฒ ๐๐๐น๐น ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ โก๏ธ https://ter.li/mio6hu
This is an incredible opportunity to unlock the ful…
Events
19-Sep-2024 - 21-Sep-2024
Magnus Group gladly invites you to attend in person or virtually in the โ11th Edition of Global Conference on Pharmaceutics and Drug Delivery Systemsโ (PDDS 2024) which will take place in Rome, Italy, on September 19-21, 2024.
The subject for this global Conference is " Advancements in Pharmaceutics: Navigating the Future of Drug Delivery ".The most recent and ongoing innovations in the pharmaceutical sector will be the main subjects of discussion at Pharma Conferences in 2024. Through a range of cutting-edge methods, the pharmaceutical industry has advanced the development of new drugs. Pharmaceutical Conference will bring together scientists, researchers, students, and pharmacologists to debate this innovative invention. Pharma Congress aims to bring together distinguished speakers and p…
EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.The 24th EuroQSAR Symposium, entitled "Synergizing AI and Multiscale Modeling for Drug Discovery", is organised on behalf of QCMS and is chaired by Jordi Mestres (University of Girona).
The symposium will focus on:
Artificial Intelligence in Drug Discovery
Generative Models
Hansch & Fujita Awards
Multiscale Modelling
New Drug Modalities
New Trends in Molecular Dynamics
Protein Design
QSAR without Borders
Synthetic Data
Target-Oriented Drug Discovery
The Challenges Ahead
Translational Safety
Ultra-Large Chemical Spaces
The scientific program of the Symposium will include 9 plenary lec…
The Women's Health Innovation Summit builds the roadmap to success by uniting the entire ecosystem of stakeholders and key opinion leaders to facilitate connections, share cutting-edge knowledge, and provide a platform for deep market expertise to flourish. Our purpose is simple: to take women's health to the next level.
Our agenda is created to maximize opportunities to meet new partners at the event and to showcase the most exciting startups in the space.
Women's health is no longer just a mission, it's a business opportunity. Explore the WHIS experience to find out how we bring the community together to facilitate growth.
URLs:Tickets: https://go.evvnt.com/2369683-0?pid=185LinkedIn: https://go.evvnt.com/2369683-2?pid=185
Prices:NPO/ CHARITY/ GOVERNMENT/ CLINICIAN RATE (e…
Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, AstraZeneca, Amgen, Akero Therapeutics and more that hold huge promise in Phase 1, 2, and 3 clinical trials. Paired with the boom of GLP-1s, these milestones have reinvigorated investment throughout the metabolic space.
The 8th MASH Drug Development Summit is the perfect forum to unite and discuss the evolving drug development opportunity for MASH and metabolic diseases. From optimizing clinical trial design to overcoming regulatory challenges, combatting fibrosis, navigating GLP-1 usage, optimizing RWE integration and achieving accurate non-invasive biomarkers, you won't find this industry-led insight anywhere else.
Join 120+ C-Level cardiometabo…
The clinical potential of radiopharmaceuticals is huge and with continued multi-billion-dollar investments from pharmaceutical giants such as Novartis, AstraZeneca, BMS and Eli Lilly, advancing your radiopharmaceutical manufacturing processes to keep up with the pace of innovation and ensure trials can progress is crucial.
The 2nd Targeted Radiopharmaceuticals Supply Chain and Manufacturing summit returns as the only industry driven forum dedicated to advancing your radiopharmaceutical production to build reliable supply of products and accelerate trials.
Discover how to streamline your production capabilities and create a stringent supply chain network through uncovering key topics such as, isotope production, radiolabelling, quality control, regulatory considerations and supply network l…
Join us at the inaugural Novel Targeting Moiety and Payload Conjugate Summit Europe, the premier event for Europe's burgeoning novel drug conjugate market. With more companies than ever before utilising novel targeting moieties and novel payloads to widen the therapeutic index of their conjugate, this meeting will act as your gateway to explore how design approaches range from peptide-drug conjugates, bispecific-drug conjugates, antibody-oligonucleotide conjugates, radio-conjugates, and fragment drug conjugates.
Learn how alterations in the targeting moiety and payload can enhance target specificity and reduce off-target toxicity, improve tumour penetration in solid tumours, prevail over oligonucleotide delivery challenges, and improve PK properties to maximise efficacy and reduce toxicity…
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance. However, treating patients with RAS mutant cancers remains no easy feat, as knowledge gaps persist in improving the depth and durability of response, tackling emerging resistance mechanisms and informing combination strategies to improve the standard-of care for patients in need.
Owing to this, the 6th Annual RAS-Targeted Drug Development Summit returns as the central hub dedicated to every aspect of discovery and development of RAS, fro…
With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging investment has reinvigorated the space with new targets, mechanisms, and technologies to transform the mental health treatment landscape.
Capitalizing on a new wave of pipeline momentum, the 7th Neuropsychiatric Drug Development Summit returns as the industry's premier gathering, showcasing the latest circuit-based target innovation, EEG and digital biomarker data, in vivo and in vitro model advances, pioneering precision psychiatry approaches and more.
Join discovery, preclinical, translational, clinical, regulatory, and commercial experts from Karuna, Janssen, AbbVie, Otsuka, Sage Therapeutics, Lykos, Lundbeck, Compass, Biogen, Delix Therapeutic…
The spotlight continues to shine on lipid nanoparticles as the 'go-to' delivery vehicle, however the demand remains to translate learnings from vaccine LNP-mRNA success into therapeutic applications. Positioned as a delivery vehicle with no ceiling to innovation, drug developers across the field are continuing to progress research to target the previously unreachable and treating the undruggable. Pinpoint the lipid components and structural complexities, advance formulative strategy and streamline manufacture to revolutionise your LNP design.
The 3rd Lipid Nanoparticles Development Summit Europe is your premier forum to collaborate with a carefully curated community of experts across Discovery, Characterisation, Translatability, Formulation, Biodistribution, Manufacturing and much more. Th…
The best and largest assembly of competitive intelligence executives in pharma, biotech, and medical devices for 15+ years! The Pharma CI USA Conference & Exhibition (September 25-26, 2024) is the gold standard for senior-level industry professionals who seek the latest in competitive and business intelligence.
Join us at this premier gathering and network with other key decision makers as you learn about the most pressing and relevant issues facing the competitive intelligence community today. Attend and take advantage of the highest ratio of industry practitioners (pharma, biotech, medical device, and diagnostics) of any pharma intelligence conference! This is the only event featuring a world-class lineup of speakers offering their unique insights and expertise on the topics you care…
25-Sep-2024 - 27-Sep-2024
The marcus evans 15th Edition Next Generation Biotherapeutics Formulation, Process Development & Delivery Forum conference taking place in Cologne, Germany on 25-27 September, 2024 will explore new innovation and challenges in protein formulation for novel modalities targeting stability, high concentration, aggregation, and immunogenicity, impacting drugs like monoclonal antibodies, biospecifics, peptides, ADCs, AAV, and DNA/RNA-based therapies. Weโll discuss the design, scale up and CMC strategies using predictive, AI/ML tools to optimise formulation and delivery within complex interactions, improving lab efficiency through automation and mitigate risks and predictions. Weโll look at end to end process optimisation to maintain quality of product, while enhancing stability during deliv…
The University of Chicago Blood Cancer and Gene Therapy Conference offers clinicians a premier platform to engage in insightful discussions and gain in-depth knowledge on the latest breakthroughs in the treatment of blood cancer and gene therapy. Featuring distinguished speakers and a focus on fostering collaboration at both regional and international levels, the conference aims to drive transformative outcomes in the field.
The chosen venue for this event holds immense symbolic importance, as it stands at the crossroads where Asia, Africa, and Europe converge. This geographical advantage facilitates the seamless exchange of knowledge and ideas from diverse corners of the world, enriching the conference experience.
Dedicated to the well-being of patients and the continuous growth of health…
30-Sep-2024 - 01-Oct-2024
We are happy to announce the upcoming Lambda Research Groupโs International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
We are happy to announce the upcoming Lambda Research Groupโs International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
โWe are happy to announce the upcoming Lambda Research Groupโs International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine during 30 Sep 2024 - 01 Oct 2024 at London, UK.
For more about our event, visit: https://lambdaconferences.com/physiotherapy/
The conference aims to bring together students, physiotherapists, sports medicine professionals, medical faculty and researchers with the aim of exploring the latest developments in the field of physical therapy and sports medicine. The conference focuses on topics such as exercise science, injury prevention, physiologists, kinesiologists, physical therapists, athlete trainers, rehabilitation and nutrition. The unique event includes keynote lectures, panel discussions, workshops, and plenty of opportunity for b…
30-Sep-2024 - 01-Oct-2024
โWe are happy to announce the upcoming Lambda Research Groupโs International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, UK.
For more about our event, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
We are happy to announce the upcoming Lambda Research Groupโs International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine from 30 Sep 2024 - 01 Oct 2024 in London, visit: https://lambdaconferences.com/physiotherapy/
30-Sep-2024 - 01-Oct-2024
โWe are happy to announce the upcoming Lambda Research Groupโs International Conference On Physiotherapy, Physical Rehabilitation & Sports Medicine during 30 Sep 2024 - 01 Oct 2024 at London, UK.
For more about our event, visit: https://lambdaconferences.com/physiotherapy/
The conference aims to bring together students, physiotherapists, sports medicine professionals, medical faculty and researchers with the aim of exploring the latest developments in the field of physical therapy and sports medicine. The conference focuses on topics such as exercise science, injury prevention, physiologists, kinesiologists, physical therapists, athlete trainers, rehabilitation and nutrition. The unique event includes keynote lectures, panel discussions, workshops, and plenty of opportunity for b…
Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond. From pioneering the next generation of CAR-M therapies to unveiling novel targets, this field is on a mission to learn from the past and spearhead pipelines into clinical development.
With that, the 6th Macrophage-Directed Therapies Summit will return to Boston this year, uniting 60+ biopharma and academia leaders across R and D, Discovery, Biology, Translational, and Clinical Development fields. As a uniquely positioned platform, this event is perfect for those committed to reigniting excitement in macrophage pipeline advancement.
This is your chance to gain exclusive insig…
Attention all Macrophage Experts! ๐ข
If you're looking to learn from the past and ๐ฝ๐ฟ๐ผ๐ฝ๐ฒ๐น ๐๐ผ๐๐ฟ ๐บ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐๐ผ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ, look no further than the ๐ฒ๐๐ต ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐ฝ๐ต๐ฎ๐ด๐ฒ-๐๐ถ๐ฟ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐ฆ๐๐บ๐บ๐ถ๐!
๐๐๐น๐น ๐๐ด๐ฒ๐ป๐ฑ๐ฎ ๐๐ฒ๐ฟ๐ฒ โก๏ธ https://ter.li/mio6hu
๐จ๐ป๐ถ๐๐ถ๐ป๐ด ๐ฒ๐ฌ+ ๐ฏ๐ถ๐ผ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ ๐ฎ๐ป๐ฑ ๐ฎ๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฎ ๐น๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐ across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.๐ก
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐๐ต๐ฒ ๐๐๐น๐น ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ โก๏ธ https://ter.li/mio6hu
This is an incredible opportunity to unlock the ful…
